
    
      Additional Study Purpose Details: Phase I safety and pharmacokinetics study.

      Detailed Description:

      The study was terminated on 11/12/2008. There were no safety findings in this trial that
      resulted in the decision to terminate the trial. The study was closed in order to change the
      amount of drug that subjects would take and to shorten the number of days that the drug would
      be taken in a new study.
    
  